Christine Dehner

Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte–colony‐stimulating factor by single‐dose administration of AMD3100, a CXCR4 antagonist

W. Conrad Liles, Elin Rodger, Hal E. Broxmeyer et al. · Transfusion · 2005 · 230 citations · Full text

Medicine, Hematology, Pharmacology +15

Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001

Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon et al. · Blood · 2023 · 171 citations · Full text

Medicine, Oncology, Hematologic Oncology +11

Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study

Michael Wang, Tanya Siddiqi, Leo I. Gordon et al. · Journal of Clinical Oncology · 2023 · 94 citations · Full text

Medicine, Oncology, Hematologic Oncology +7

Safety and Preliminary Efficacy in Patients with Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel in Transcend NHL 001

Maria Lia Palomba, Leo I. Gordon, Tanya Siddiqi et al. · Blood · 2020 · 65 citations

Medicine, Oncology, Pharmacology +12

Two-Year Follow-up of Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed or Refractory (R/R) Large B-Cell Lymphomas (LBCL)

Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon et al. · Blood · 2021 · 57 citations

Medicine, Hematology, Oncology +10